SynDevRx is a drug development company with offices in Scottsdale, Arizona, and Cambridge, Massachusetts. The company's team has decades of oncology drug development expertise and is focused on developing novel drug conjugates to treat unmet medical needs for cancer patients. Their drugs are designed to treat the tumor directly and improve underlying metabolic hormone dysfunction. SynDevRx aims to commercialize their drug conjugates through partnerships with industry leaders, leveraging their best-in-class technology and world-class scientific advisory board comprised of clinical oncology Key Opinion Leaders.